Correlation Between Sangamo Therapeutics and Actinium Pharmaceuticals

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Sangamo Therapeutics and Actinium Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Sangamo Therapeutics and Actinium Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Sangamo Therapeutics and Actinium Pharmaceuticals, you can compare the effects of market volatilities on Sangamo Therapeutics and Actinium Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Sangamo Therapeutics with a short position of Actinium Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Sangamo Therapeutics and Actinium Pharmaceuticals.

Diversification Opportunities for Sangamo Therapeutics and Actinium Pharmaceuticals

-0.25
  Correlation Coefficient

Very good diversification

The 3 months correlation between Sangamo and Actinium is -0.25. Overlapping area represents the amount of risk that can be diversified away by holding Sangamo Therapeutics and Actinium Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Actinium Pharmaceuticals and Sangamo Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Sangamo Therapeutics are associated (or correlated) with Actinium Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Actinium Pharmaceuticals has no effect on the direction of Sangamo Therapeutics i.e., Sangamo Therapeutics and Actinium Pharmaceuticals go up and down completely randomly.

Pair Corralation between Sangamo Therapeutics and Actinium Pharmaceuticals

Given the investment horizon of 90 days Sangamo Therapeutics is expected to generate 1.47 times more return on investment than Actinium Pharmaceuticals. However, Sangamo Therapeutics is 1.47 times more volatile than Actinium Pharmaceuticals. It trades about 0.09 of its potential returns per unit of risk. Actinium Pharmaceuticals is currently generating about -0.04 per unit of risk. If you would invest  63.00  in Sangamo Therapeutics on August 26, 2024 and sell it today you would earn a total of  125.00  from holding Sangamo Therapeutics or generate 198.41% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Sangamo Therapeutics  vs.  Actinium Pharmaceuticals

 Performance 
       Timeline  
Sangamo Therapeutics 

Risk-Adjusted Performance

14 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Sangamo Therapeutics are ranked lower than 14 (%) of all global equities and portfolios over the last 90 days. In spite of very uncertain primary indicators, Sangamo Therapeutics displayed solid returns over the last few months and may actually be approaching a breakup point.
Actinium Pharmaceuticals 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Actinium Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's basic indicators remain very healthy which may send shares a bit higher in December 2024. The recent disarray may also be a sign of long period up-swing for the firm investors.

Sangamo Therapeutics and Actinium Pharmaceuticals Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Sangamo Therapeutics and Actinium Pharmaceuticals

The main advantage of trading using opposite Sangamo Therapeutics and Actinium Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Sangamo Therapeutics position performs unexpectedly, Actinium Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Actinium Pharmaceuticals will offset losses from the drop in Actinium Pharmaceuticals' long position.
The idea behind Sangamo Therapeutics and Actinium Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Efficient Frontier module to plot and analyze your portfolio and positions against risk-return landscape of the market..

Other Complementary Tools

Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges